Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 3Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Colorectal Neoplasms 12Rectal Neoplasms 7Colonic Neoplasms 5Pancreatic Neoplasms 3Stomach Neoplasms 2Glioblastoma 2Breast Neoplasms 2Biliary Tract Neoplasms 2Uterine Cervical Neoplasms 1Solid Tumor Malignancy 1Small Cell Lung Carcinoma 1Sarcoma, Ewing 1Sarcoma 1Prostatic Neoplasms 1Pediatric Solid Tumors 1Ovarian Neoplasms 1Oligodendroglioma 1Neoplasm Metastasis 1Lung Neoplasms 1Gliosarcoma 1Gallbladder Neoplasms 1Colorectal Adenocarcinoma Metastatic to the Liver 1Central Nervous System Neoplasms 1Breast Neoplasms, Male 1Brain Neoplasms 1Borderline Resectable Pancreatic Adenocarcinoma 1Astrocytoma 1

Interventions

vinflunine 1vandetanib 1tipifarnib 1Trastuzumab 1Irinotecan 1Immunoenzyme Techniques 1Goserelin 1Fluorodeoxyglucose F18 1Flow Cytometry 1Echocardiography 1Docetaxel 1Cyclophosphamide 1Capecitabine 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Breast Neoplasms, Male × Irinotecan × Clear all
NCT01939483 2014-10-08

A Pilot Study of Irinotecan in Patients With Breast Cancer and CNS Metastases

University of California, Irvine

Phase NA Withdrawn
Breast

Breast Neoplasms, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡